The 91探花 is proud to announce that 56 faculty and researchers who completed their work while at 91探花have been named on the list from Clarivate.

The annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the .

Highly Cited Researchers demonstrate significant and broad influence in their fields of research. The total list includes 7,131 awards from more than 1,300 institutions in 60 countries and regions. This small fraction of the global researcher population contributes disproportionately to extending the frontiers of knowledge and contributing to innovations that make the world healthier, more sustainable and which drive societal impact, according to Clarivate.

The that determines the 鈥渨ho鈥檚 who鈥� of influential researchers is drawn from data and analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information at Clarivate.

The list below includes faculty and researchers whose primary affiliation is with the UW, Fred Hutch Cancer Center, and the Institute for Health Metrics and Evaluation.

Please note: Some of the people on the list are no longer with the 91探花and their current affiliation is noted. This list reflects initial data from Clarivate and may be updated.

Ivan Anishchenko (Vilya)

David Baker

William A. Banks

Gregory N. Bratman

Steven L. Brunton

Guozhong Cao

Ting Cao

Lauren Carter (Gates Medical Research Institute)

Helen Chu

David H. Cobden

Katharine H. D. Crawford

Riza M. Daza

Frank DiMaio

Kristie L. Ebi

Evan E. Eichler

Emmanuela Gakidou

David Ginger

Raphael Gottardo (CHUV)

Alexander L. Greninger

Simon I. Hay

Andrew Hill (Infinimmune)

Eric Huang

Michael C. Jensen (BrainChild)

Neil P.聽 King

C. Dirk Keene

J. Nathan Kutz

Eric H. Larson

Aaron Lyon

Michael J. MacCoss

Brendan MacLean

C. M. Marcus

Julian D. Marshall

Ali Mokdad

Thomas J. Montine (Stanford)

Mohsen Naghavi

Marian L. Neuhouser

Julian D. Olden

Robert W. Palmatier

David Pigott

Hannah A. Pliner (Bristol Myers Squibb)

Ganesh Raghu

Stanley Riddell

Andrea Schietinger (Memorial Sloan Kettering Cancer Center)

Jay Shendure

M. Alejandra Tortorici

Troy R. Torgerson (Allen Institute)

Cole Trapnell

Katherine R. Tuttle

David Veesler

Theo Vos

Alexandra C. Walls (BioNTech SE)

Bryan J. Weiner

Di Xiao

Jie Xiao

Xiaodong Xu

Jihui Yang

The 91探花 is proud to announce that 47 faculty and researchers who completed their work while at 91探花have been named on the annual list from Clarivate.

The highly anticipated annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Science citation index.

The list of faculty and researchers who were acknowledged for their work while at 91探花includes:

• David Baker
• Frank DiMaio
• William Sheffler
• Dr. Jay Shendure
• Cole Trapnell
• David Veesler
• Alexandra C. Walls*
• Philip Mease
• Dr. Christopher J. L. Murray
• Dr. Ganesh Raghu
• Dr. Stanley Riddell
• Alejandra Tortorici
• Dr. William A. Banks
• Gregory N. Bratman
• Steven L. Brunton
• Guozhong Cao
• William A. Catterall
• David H. Cobden
• Riza M. Daza
• Dr. E. Patchen Dellinger
• Dr. Janet A. Englund
• E. Erskine
• Michael Gale Jr.
• Raphael Gottardo
• Celestia S. Higano
• Neil P. King
• Ali Mokdad
• William S. Noble
• Julian D. Olden
• L. Patrick
• David L. Smith
• Dr. Piper Meigs Treuting
• Spencer A. Wood
• Jesse R. Zaneveld
• Ning Zheng
• Dr. Hans D. Ochs
• Simon I. Hay
• Evan E. Eichler
• Deborah A. Nickerson**
• John A. Stamatoyannopoulos***
• Dr. Thomas J. Montine****
• Di Xiao
• Xiaodong Xu
• Bryan J. Weiner
• Mohsen Naghavi
• Theo Vos
• David M. Pigott

The that determines the 鈥渨ho鈥檚 who鈥� of influential researchers draws on the data and analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information at Clarivate. It also uses the tallies to identify the countries and research institutions where these scientific elite are based. This year Clarivate partnered with Retraction Watch and extended the qualitative analysis of the Highly Cited Researchers list, addressing increasing concerns over potential misconduct.

The full 2022 Highly Cited Researchers list and executive summary can be found online .

* now is at BioNTech SE.

** on Dec. 24, 2021.

*** now is at Altius.

**** now is at Stanford University.

For 25 years, folks have traveled from all over the Pacific Northwest to meet for their pulmonary fibrosis support group at 91探花 Medical Center. This week, as they celebrated the support group鈥檚 quarter-century anniversary, the room buzzed with laughter, greetings, and smiles. Some members wore oxygen tanks, necessary after the disease began hardening and scarring their lung tissue and made breathing difficult.

Pulmonary fibrosis is a life-threatening disease in which excess fibrous tissue develops in the lungs. People with pulmonary fibrosis experience a hacking cough and shortness of breath that causes fatigue, weight loss, and weakness. No single cause of pulmonary fibrosis has been identified; it is often classified as a secondary effect of other interstitial lung diseases. The term 鈥渋nterstitial lung disease鈥� refers to a large group of disorders involving both lungs, most of which cause progressive scarring of lung tissue (pulmonary fibrosis). There is no cure for pulmonary fibrosis, and almost no treatment. One can only hope to be a good candidate for a successful lung transplant.

A number support group members had already received lung transplants from 91探花Medical Center鈥檚 transplant services. One gentleman received news one month ago to the day, as he was walking out of the support group, that he was to have his transplant.

Dave Sherry, the group leader, beamed as he described the bond between fellow members. Each month, he and the team organize a speaker from 91探花Medical Center or an outside medical organization to give a talk about the disease. Members also spend time voicing their fears and successes with each other.

鈥淲e have a shared destiny that ties us together,鈥� said Sherry. In fact, this support group has been so strong throughout the years that it became a model for other support groups. One prominent Italian surgeon was so impressed that he implemented a similar system of support groups in Europe.

Representatives from the Chicago-based Pulmonary Fibrosis Foundation, including CEO Dr. Daniel M. Rose, traveled to Seattle for the support group鈥檚 25^th anniversary. Rose presented a short and fascinating lecture that compared the history of cystic fibrosis with pulmonary fibrosis. He emphasized the need for research and clinical trials, and showed how the Cystic Fibrosis Foundation鈥檚 aggressive approach to finding treatment for the disease ultimately improved the estimated lifespan of patients by more than 25 years. His goal is to approach pulmonary fibrosis with the same commitment to finding treatment and finding a cure.

Indeed, this month鈥檚 support group was particularly celebratory. In addition to the 25-year anniversary, this past week 91探花Medicine announced the formation of the Center for Interstitial Lung Disease. The Center鈥檚 founding director is , 91探花professor of medicine in the Division of Pulmonary and Critical Care Medicine and co-director of 91探花Medical Center鈥檚 scleroderma clinic. Raghu is also the prescient doctor who had the foresight to start the long-running support group鈥攖he first of its kind in the world.

Said Raghu, 鈥漈he establishment of the Center for Interstitial Lung Diseases is an essential expansion of a long standing interstitial lung disease /sarcoidosis/pulmonary fibrosis program at 91探花Medical Center. The initiative will result in more accurate diagnoses聽and better outcomes for patients confronted with the challenges of interstitial lung diseases. This is the beginning of a new and exciting era of聽substantial progress for our patients, who will now receive care tailored to the individual patient鈥檚 preference and choice based on current and new evidence. It is my most sincere privilege and honor to serve our patients and to work with everyone at 91探花Medical Center. It is a superb clinical and research聽environment, committed to maintaining and restoring health for those in need.鈥�

For 91探花Medicine, establishing the Center for Interstitial Lung Disease means more opportunities for research, collaboration, training, and technology. For these incredible patients, who have supported each other for so long, the Center could mean a new lease on life.